END-POINTS FOR MULTIMODAL CLINICAL-TRIALS IN STAGE-III NONSMALL CELL LUNG-CANCER (NSCLC) - A CONSENSUS REPORT

被引：30

作者：

GREEN, MR

COX, JD

ARDIZZONI, A

ARRIAGADA, R

BUREAU, G

DARWISH, S

DENEFFE, G

FUKUOKA, M

JOSEPH, D

KOMAKI, R

MIRIMANOFF, RO

MORNEX, F

PALAZZI, M

PASTORINO, U

PAVY, JJ

POSTMUS, PE

ROTH, J

RUBIN, P

SAIJO, N

SAUNDERS, M

STOUT, R

SUTEDJA, TG

TROVO, MG

机构：

[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT THORAC SURG,HOUSTON,TX

[2] INST GUSTAVE ROUSSY,VILLEJUIF,FRANCE

[3] GRP MED ST REMY,REIMS,FRANCE

[4] UNIV ZIEKENHUIS PELLENBERG,LUBBEEK,BELGIUM

[5] GEELONG HOSP,GEELONG,VIC,AUSTRALIA

[6] UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT TUMOR BIOL,HOUSTON,TX 77030

[7] CTR LEON BERARD,LYON,FRANCE

[8] HOP JEAN MINJOZ,BESANCON,FRANCE

[9] UNIV ROCHESTER,CTR CANC,ROCHESTER,NY

[10] IST NAZL TUMORI,DEPT THORAC SURG,MILAN,ITALY

[11] CHRISTIE HOSP,MANCHESTER,LANCS,ENGLAND

[12] CRO,PORDENONE,ITALY

[13] FREE UNIV AMSTERDAM HOSP,AMSTERDAM,NETHERLANDS

[14] CHU VAUDOIS,LAUSANNE,SWITZERLAND

来源：

LUNG CANCER | 1994年 / 11卷

关键词：

D O I：

10.1016/0169-5002(94)91859-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：S11 / S13

页数：3